Natalia Vlcek Zasepa
About Natalia Vlcek Zasepa
Natalia Vlcek Zasepa serves as the Head of Safety and Pharmacovigilance EMEA at Amylyx Pharmaceuticals, bringing extensive experience in pharmacovigilance and quality assurance from her previous roles in various pharmaceutical companies and CROs.
Current Role at Amylyx Pharmaceuticals
Natalia Vlcek Zasepa serves as the Head of Safety and Pharmacovigilance EMEA at Amylyx Pharmaceuticals. She has held this position since 2022, working from the company's office in Amsterdam, North Holland, Netherlands. In this role, she oversees safety monitoring and pharmacovigilance activities across the EMEA region, ensuring compliance with regulatory requirements and maintaining high standards of patient safety.
Previous Experience in Pharmacovigilance
Prior to her current role, Natalia Vlcek Zasepa accumulated significant experience in pharmacovigilance. She worked as a Safety Officer at Julius Clinical from 2015 to 2016 and at Cardialysis from 2018 to 2020. Additionally, she served as the EU QPPV and Pharmacovigilance Manager at Arriello from 2020 to 2022. Her roles involved managing safety data and ensuring adherence to quality standards in clinical settings.
Career Background at Xendo
Natalia Vlcek Zasepa worked at Xendo for ten years, from 2005 to 2015, where she held the positions of Team Leader for the Adverse Event Management Team and Global Quality Assurance Manager. During her tenure in the Rotterdam Area, Netherlands, she developed expertise in managing adverse event reporting and quality assurance processes within the pharmaceutical industry.
Educational Background in Medical Biology
Natalia Vlcek Zasepa studied Medical Biology at Universiteit Leiden, where she earned a Master of Science (MSc) degree from 1996 to 2001. This educational foundation provided her with a strong understanding of biological sciences, which supports her work in pharmacovigilance and safety management.
Multicultural Experience and Language Skills
Natalia Vlcek Zasepa has extensive experience working in multicultural environments, collaborating with both pharmaceutical companies and Contract Research Organizations (CROs). Her strong command of multiple languages enhances her ability to communicate effectively within diverse teams, facilitating collaboration across various regions and cultures.